Your Messages Inbox
Your Article Summary
See Latest ArticlesNabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09
Nabi Biopharmaceuticals announced that it has completed the sale of PentaStaph (Pentavalent S. aureus Vaccine) and related assets to GlaxoSmithKline PLC (GSK). The sale was announced in August of this year. Under the terms of the agreement, Nabi will receive cash payments of $21.5 million of which $20 million is associated with the PentaStaph transaction close, $1 million associated with the sale of a separate pre–clinical program for a vaccine against S.epidermedis, as well as $0.5 million as reimbursement for license fees and clinical materials previously manufactured for use in the Phase I trial.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Results from two Phase II trials add to understanding of ticagrelor and how it works in the body
AstraZeneca, 11/19/09
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
Genzyme, 11/19/09
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
HP to Acquire Networking Firm 3Com
HealthDataManagement, 11/20/09
Protox Reports 2009 Third Quarter Results
Protox Therapeutics , 11/18/09
King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
King Pharmaceuticals, 11/16/09
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Carillion to install bedside terminals at LHSC
Canadian Healthcare Technology, 11/20/09
Vendor Partnership Targets HIEs
HealthDataManagement, 11/20/09
Consultancy, Open Source Firm Target HIEs
HealthDataManagement, 11/20/09
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09
Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09
Genzyme Receives Complete Response Letter on Lumizyme Application
Genzyme, 11/17/09
Article Search
Sponsor